Longitude Capital
Menlo Park, United States · Growth → Series C+
Their stated focus (public profile)
Longitude Capital specializes in venture growth investments in biotechnology, medical technology, and health solutions companies. The fund targets both privately held and publicly traded companies at clinical-stage and commercial-stage, seeking clinically de-risked assets with favorable risk-adjusted valuations and expected returns within three to five years. It employs a variety of structures including traditional VC, PIPEs, asset spin-outs, recapitalizations, royalties, and open market purchases.
Stages: Growth → Series C+
Sectors: Life sciences, Medtech
On file: 40 companies on record
Website: longitudecapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.